1. Xu, Wei, Tan, Lan, Yu, Jin-Tai. 2014. Link between the SNCA gene and parkinsonism. In Neurobiology of aging, 36, 1505-18. doi:10.1016/j.neurobiolaging.2014.10.042. https://pubmed.ncbi.nlm.nih.gov/25554495/
2. Fedotova, Ekaterina Yu, Iakovenko, Elena V, Abramycheva, Natalia Yu, Illarioshkin, Sergey N. 2023. SNCA Gene Methylation in Parkinson's Disease and Multiple System Atrophy. In Epigenomes, 7, . doi:10.3390/epigenomes7010005. https://pubmed.ncbi.nlm.nih.gov/36810559/
3. Polymeropoulos, M H, Lavedan, C, Leroy, E, Golbe, L I, Nussbaum, R L. . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. In Science (New York, N.Y.), 276, 2045-7. doi:. https://pubmed.ncbi.nlm.nih.gov/9197268/
4. Jahabardeen, Afrarahamed, S, Nirenjen, J, Narayanan, V, Chitra. 2024. A Review on the Role of SNCA Gene in Neurodegenerative Diseases. In Cureus, 16, e69450. doi:10.7759/cureus.69450. https://pubmed.ncbi.nlm.nih.gov/39411638/
5. Zafar, Faria, Nallur Srinivasaraghavan, Vasavi, Yang Chen, Max, Alejandra Morato Torres, C, Schüle, Birgitt. 2022. Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson's disease. In Stem cell research, 60, 102733. doi:10.1016/j.scr.2022.102733. https://pubmed.ncbi.nlm.nih.gov/35263701/
6. Guhathakurta, Subhrangshu, Song, Min Kyung, Basu, Sambuddha, Cristovao, Ana Clara, Kim, Yoon-Seong. 2022. Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease. In International neurourology journal, 26, S85-93. doi:10.5213/inj.2222206.103. https://pubmed.ncbi.nlm.nih.gov/36503211/
7. Yoon, Hyung Ho, Ye, Sunghyeok, Lim, Sunhwa, Hur, Junseok W, Jeon, Sang Ryong. . CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo. In The CRISPR journal, 5, 95-108. doi:10.1089/crispr.2021.0025. https://pubmed.ncbi.nlm.nih.gov/35191750/
智鼠故事 
